Comments
Loading...

Repligen Corp (RGEN) Stock Price, Quote, News & History

RGENNASDAQ
$136.44
3.812.87%
At close: Feb 13, 4:00 PM EST
$136.44
N/A
After Hours: 4:00 PM EST
Earnings: Q4 2025 Earnings in 10 days from now on Tue Feb 24th, before the market open

Key Statistics

Open
$133.97
Close
$136.44
Volume / Avg.
767.02K / 699.74K
Day Range
$133.39 - $140.75
52 Wk Range
102.97 - 175.77
Market Cap
$7.68B
P/E Ratio
6.63K
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
9.71%
Days to Cover
6.77
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
130.89M
Investing Cash Flow (TTM)
-154.49M
Financing Cash Flow (TTM)
-13.95M
Free Cash Flow (TTM)
103.47M
Capital Expenditure (TTM)
-27.42M
Net Change in Cash (TTM)
-37.55M

Analyst Trends and Forecast

2
Sep 25
4
Oct 25
2
Dec 25
1
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$7.94B
PE Ratio (TTM)
6631.50
PE Ratio (FWD)
70.92
PEG Ratio (TTM)
-
PS Ratio (TTM)
10.52
PB Ratio (TTM)
3.58
Earnings Yield % (TTM)
0.02%
Earnings Yield % (FWD)
1.41%
EV / EBITDA (TTM)
61.20
Price / EBITDA (TTM)
61.56
Price / Free Cash Flow (TTM)
72.00
Book Value / Share
$37.01

Company Debt

Total Debt
$537.93M
LT Debt
$537.93M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
$0
Total Cash
$748.75M
Debt to Equity
0.33
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
$0

Key Statistics

Open
$133.97
Close
$136.44
Volume / Avg.
767.02K / 699.74K
Day Range
$133.39 - $140.75
52 Wk Range
102.97 - 175.77
Market Cap
$7.68B
P/E Ratio
6.63K
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
9.71%
Days to Cover
6.77

About

Sector
Health Care
Industry
Life Sciences Tools & Services
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGEN
MEDP

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Repligen (RGEN) competitors?

Q

What is the forecast, or price target, for Repligen (RGEN) stock?

A

Repligen has a consensus price target of $181.72.

Q

What is the current price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $136.44 last updated February 13, 2026 at 4:00 PM EST.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen does not have any upcoming earnings scheduled.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.